Peak exercise responses in heart failure: Back to basics

European Heart Journal

Volumn 30, Issue 24, 2009, Pages 2962-2964

  Cohen Solal, Alain ^a   Beauvais, Florence ^a   Tan, Lip Bun ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL;

ARTERIAL PRESSURE; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR RISK; EDITORIAL; EXERCISE; HEART FAILURE; HEART FUNCTION; HEART OUTPUT; HEMODYNAMICS; HUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

CARBAZOLES; EXERCISE; EXERCISE TOLERANCE; HEART FAILURE; HEMODYNAMICS; HUMANS; OXYGEN CONSUMPTION; PROPANOLAMINES; VASODILATOR AGENTS;

EID: 72649099025     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp176     Document Type: Editorial

References (22)

1. Sarnoff SJ, Berglund E. Ventricular function. I. Starling's law of the heart studied by means of simultaneous right and left ventricular function curves in the dog. Circulation 1954;9:706-718.
2. Benge W, Litchfield RL, Marcus ML. Exercise capacity in patients with severe left ventricular dysfunction. Circulation 1980;61:955-959.
3. Franciosa J, Park M, Levine T. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981; 47:33-39.
4. Mancini D, Eisen H, Kussmaul W, Mull R, Edmunds L, Wilson J. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients. Circulation 1991;83:778-786.
5. Chomsky DB, Lang CC, Rayos GH, Shyr Y, Yeoh TK, Pierson RN 3rd, Davis SF, Wilson JR. Hemodynamic exercise testing: a valuable tool in the selection of cardiac transplantation candidates. Circulation 1996;94:3176-3183.
6. Mancini D, Katz S, Donchez L, Aaronson K. Coupling of hemodynamic measurements with oxygen consumption during exercise does not improve risk stratification in patients with heart failure. Circulation 1996;94:2492-2496.
7. Mancini D, LeJemtel T, Aaronson K. Peak VO(2): a simple yet enduring standard. Circulation 2000;101:1080-1082
8. Franklin KJed. A Short History of Physiology. London: Bale, 1933.
9. Corrà U, Mezzani A, Giordano A, Bosimini E, Giannuzzi P. Exercise haemo-dynamic variables rather than ventilatory efficiency indexes contribute to risk assessment in chronic heart failure patients treated with carvedilol. Eur Heart J 2009;30:3000-3006. First published on 30 April 2009. doi:10.1093/eurheartj/ ehp138
10. Osada N, Chaitman B, Miller L, Yip D, Cishek MB, Wolford TL, Donohue TJ. Car-diopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation. J Am Coll Cardiol 1998;31:577-582.
11. Tan L. Cardiac pumping and prognosis in heart failure. Lancet 1986;ii:1360-1363.
12. Cotter G, Williams SG, Vered Z, Tan LB. Role of cardiac power in heart failure. Curr Opin Cardiol 2003;18:215-222.
13. Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, LeJemtel TH, Cotter G; SHOCK Investigators. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 2004;44:340-348.
14. Roul G, Moulichon M, Bareiss P, Gries P, Koegler A, Sacrez J, Germain P, Mossard JM, Sacrez A. Prognostic factors of chronic heart failure in NYHA class II or III: value of invasive exercise haemodynamic data. Eur Heart J 1995; 16:1387-1398.
15. Metra M, Faggiano P, D'Aloia A, Nodari S, Gualeni A, Raccagni D, Dei Cas L. Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol 1999;33:943-950.
16. Marmor A, Schneeweiss A. Prognostic value of noninvasively obtained left ventricular contractile reserve in patients with severe heart failure. J Am Coll Cardiol 1997;29:422-428.
17. Williams SG, Cooke GA, Wright DJ, Parsons WJ, Riley RL, Marshall P, Tan LB. Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J 2001;22: 1496-1503
18. Lang CC, Karlin P, Haythe J, Tsao L, Mancini DM. Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure. Am J Cardiol 2007;99: 404-405.
19. Cohen-Solal A, Tabet J, Logeart D, Bourgoin P, Tokmakova M, Dahan M. A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure. Eur Heart J 2002;23:806-814.
20. Giardini A, Specchia S, Berton E, Sangiorgi D, Coutsoumbas G, Gargiulo G, Oppido G, Bonvicini M, Picchio FM. Strong and independent prognostic value of peak circulatory power in adults with congenital heart disease. Am Heart J 2007;154:441-447.
21. Tabet JY, Metra M, Thabut G, Logeart D, Cohen-Solal A. Prognostic value of cardiopulmonary exercise variables in chronic heart failure patients with or without beta-blocker therapy. Am J Cardiol 2006;98:500-503.
22. Williams SG, Tzeng BH, Barker D, Tan LB. Comparison and relation of indirect and direct dynamic indexes of cardiac pumping capacity in chronic heart failure. Am J Cardiol 2005;96:1149-1150.